PCO-Syndrom Willkkommen PCO-Syndrom ‹berblick PCO-Syndrom Ursachen PCO-Syndrom Beschwerden PCO-Syndrom Diagnose PCO-Syndrom Behandlung PCO-Syndrom Forschung PCO-Syndrom Kontakt

Publikationen | PCO-Syndrom

Walch K, Grimm C, Zeillinger R, Huber JC, Nagele F, Hefler LA. A common interleukin-6 gene promoter polymorphism influences the clinical characteristics of women with polycystic ovary syndrome. Fertil Steril. 2004 Jun;81(6):1638-41.

Walch K, Nagele F, Zeillinger R, Vytiska-Binstorfer E, Huber JC, Hefler LA. A polymorphism in the matrix metalloproteinase-1 gene promoter is associated with the presence of polycystic ovary syndrome in Caucasian women. Fertil Steril. 2005 May;83(5):1565-7.

Walch K, Grimm C, Huber JC, Nagele F, Kolbus A, Hefler LA. A polymorphism of the plasminogen activator inhibitor-1 gene promoter and the polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol. 2005 Nov 1;123(1):77-81.

Walch K, Grimm C, Nagele F, Huber J, Wolfler M, Vytiska-Binstorfer E, Unfried G, Hefler LA. Impaired glucose tolerance is associated with changes in clinical and biochemical parameters in women with polycystic ovary syndrome. Acta Obstet Gynecol Scand. 2006;85(7):869-73